Merck & Co., Inc. (BVMF:MRCK34)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.20 trillion. The enterprise value is 1.32 trillion.

Market Cap	1.20T
Enterprise Value	1.32T

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Sep 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.63%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 11.85 and the forward PE ratio is 10.38.

PE Ratio	11.85
Forward PE	10.38
PS Ratio	3.51
PB Ratio	4.35
P/TBV Ratio	15.09
P/FCF Ratio	17.28
P/OCF Ratio	13.22
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.45, with an EV/FCF ratio of 19.05.

EV / Earnings	13.06
EV / Sales	3.90
EV / EBITDA	8.45
EV / EBIT	10.03
EV / FCF	19.05

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.40
Debt / FCF	3.17
Interest Coverage	19.57

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 17.71%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	12.61%
Return on Invested Capital (ROIC)	17.71%
Return on Capital Employed (ROCE)	24.71%
Revenue Per Employee	4.63M
Profits Per Employee	1.37M
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 14.77 billion in taxes.

Income Tax	14.77B
Effective Tax Rate	12.71%

Stock Price Statistics

The stock price has decreased by -22.48% in the last 52 weeks. The beta is 0.32, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-22.48%
50-Day Moving Average	56.84
200-Day Moving Average	58.49
Relative Strength Index (RSI)	60.29
Average Volume (20 Days)	2,514

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.16

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 342.33 billion and earned 101.44 billion in profits. Earnings per share was 40.27.

Revenue	342.33B
Gross Profit	266.51B
Operating Income	132.88B
Pretax Income	116.27B
Net Income	101.44B
EBITDA	155.98B
EBIT	132.88B
Earnings Per Share (EPS)	40.27

Balance Sheet

The company has 97.07 billion in cash and 220.50 billion in debt, giving a net cash position of -123.43 billion.

Cash & Cash Equivalents	97.07B
Total Debt	220.50B
Net Cash	-123.43B
Net Cash Per Share	n/a
Equity (Book Value)	276.63B
Book Value Per Share	111.09
Working Capital	100.88B

Cash Flow

In the last 12 months, operating cash flow was 90.95 billion and capital expenditures -21.40 billion, giving a free cash flow of 69.54 billion.

Operating Cash Flow	90.95B
Capital Expenditures	-21.40B
Free Cash Flow	69.54B
FCF Per Share	n/a

Margins

Gross margin is 77.85%, with operating and profit margins of 38.82% and 29.63%.

Gross Margin	77.85%
Operating Margin	38.82%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	45.56%
EBIT Margin	38.82%
FCF Margin	20.31%

Dividends & Yields

This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 2.75%.

Dividend Per Share	1.58
Dividend Yield	2.75%
Dividend Growth (YoY)	16.11%
Years of Dividend Growth	2
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	3.67%
Earnings Yield	8.44%
FCF Yield	5.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	8

Scores

Merck & Co. has an Altman Z-Score of 3.83 and a Piotroski F-Score of 5.

Altman Z-Score	3.83
Piotroski F-Score	5